{"id":10519,"date":"2026-09-12T10:26:29","date_gmt":"2026-09-12T07:26:29","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10519"},"modified":"2026-09-12T10:26:29","modified_gmt":"2026-09-12T07:26:29","slug":"copd-cardiovascular-risk-esc-2026","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/copd-cardiovascular-risk-esc-2026\/","title":{"rendered":"COPD &#038; Cardiovascular Risk | ESC 2026"},"content":{"rendered":"<div>COPD &amp; Cardiovascular Risk | ESC 2026<\/p>\n<p>* COPD should be viewed as a cardiopulmonary disease, not simply a respiratory disorder.<\/p>\n<p>C 2026<\/p>\n<p>* COPD is not only a lung disease: in mild\u2013moderate COPD, cardiovascular disease and cancer\u2014not respiratory failure\u2014are major causes of death.<\/p>\n<p>* Actively screen for CVD: CAD, HF, arrhythmias and pulmonary hypertension should be sought rather than waiting for symptoms.<br \/>\n* HF is common: reported in roughly 10\u201350% of COPD patients.<\/p>\n<p>* Troponin: frequently elevated during acute COPD exacerbations and does not automatically mean type-1 MI; interpret with symptoms, ECG and serial troponin.<\/p>\n<p>* CT offers a cardiovascular opportunity: chest CT performed for COPD\/lung assessment can also reveal coronary calcification and pulmonary-vessel enlargement.<br \/>\n* Echo \u2192 CMR: hyperinflation can impair echocardiographic windows; CMR is useful when echo is inadequate.<br \/>\n* Exacerbations matter: cardiovascular risk rises substantially after severe COPD exacerbations \u2192 reassess CV risk after an exacerbation.<br \/>\n* \u2060PH-COPD: PAH-targeted pulmonary vasodilators are not recommended for mild\u2013moderate PH, as benefit is unproven and they may worsen V\/Q mismatch and hypoxemia. In severe PH (PVR &gt;5 WU), individualized therapy may be considered only at an expert PH center after RHC. RHC is the gold standard for confirming\/classifying PH and distinguishing lung-related, left-heart, or mixed causes, as these findings directly influence treatment decisions.<br \/>\n* \u2060Source: ERS International Congress 2026, Barcelona \u2014 6 September 2026.Sources:<br \/>\nESC Congress 2026, Munich \u2014 28\u201331 August 2026<br \/>\nThe world\u2019s largest international respiratory medicine congress.2026, Barcelona \u2014 5\u20139 September 2026\u061b<br \/>\n<a href=\"https:\/\/www.ersnet.org\/congress-and-events\/congress\/congress-news-and-highlights\/programme-highlights-for-assemblies\/programme-highlights-pulmonary-vascular-diseases-ers-congress-2026\/\" target=\"_blank\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.ersnet.org\/congress-and-events\/congress\/congress-news-and-highlights\/programme-highlights-for-assemblies\/programme-highlights-pulmonary-vascular-diseases-ers-congress-2026\/&amp;source=gmail&amp;ust=1789284117219000&amp;usg=AOvVaw38kmmneVhtPHzv_k_yY6Xl\" rel=\"noopener\">https:\/\/www.ersnet.org\/<wbr \/>congress-and-events\/congress\/<wbr \/>congress-news-and-highlights\/<wbr \/>programme-highlights-for-<wbr \/>assemblies\/programme-<wbr \/>highlights-pulmonary-vascular-<wbr \/>diseases-ers-congress-2026\/<\/a><\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>COPD &amp; Cardiovascular Risk | ESC 2026 * COPD should be viewed as a cardiopulmonary disease, not simply a respiratory disorder. C 2026 * COPD is not only a lung disease: in mild\u2013moderate COPD, cardiovascular disease and cancer\u2014not respiratory failure\u2014are major causes of death. * Actively screen for CVD: CAD, HF, arrhythmias and pulmonary hypertension [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10519","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10519"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10519\/revisions"}],"predecessor-version":[{"id":10520,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10519\/revisions\/10520"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}